Divya Anjana Shankar, MD

Clinical Instructor, Medicine

Divya Anjana Shankar
617.358.2800

Biography

Divya Shankar MD is an Instructor in the Boston University Department of Pulmonary, Allergy, Sleep, and Critical Care Medicine and a health services researcher with an interest in studying and improving the quality and equity of care for patients with interstitial lung diseases (ILDs). Her current work leverages large, clinical databases to understand patterns of care for patients with ILDs and her long-term goal is to use implementation science methods to improve evidence-based care delivery in this population.

Other Positions

  • Fellow, Pulmonary & Critical Care Medicine, Boston Medical Center

Education

  • Boston University School of Medicine, MD
  • Boston University, BA

Publications

  • Published on 11/9/2024

    Sangani R, Bosch NA, Govender P, Scarpato B, Walkey AJ, Newman J, Law AC, Gillmeyer KR, Shankar DA. Sarcoidosis Treatment Patterns in the United States: 2016-2022. Chest. 2024 Nov 09. PMID: 39522595.

    Read at: PubMed
  • Published on 10/1/2024

    Homer-Bouthiette C, Shen BH, Dobie AC, Shankar DA, Pang B, Law AC, Bosch NA. Practice Patterns for Acute Asthma Exacerbation in Adult Patients Admitted to U.S. Intensive Care Units. Ann Am Thorac Soc. 2024 Oct; 21(10):1441-1448. PMID: 38935672.

    Read at: PubMed
  • Published on 6/22/2024

    Shen BH, Dobie AC, Shusterman SL, Duzgol M, Homer-Bouthiette C, Kearney LE, Newman J, Pang B, Shankar DA, Zhang J, Gillmeyer KR, Bosch NA, Law AC. Variation in Triage to Pediatric vs Adult ICUs Among Adolescents and Young Adults With Asthma Exacerbations. CHEST Crit Care. 2024 Sep; 2(3). PMID: 39364391.

    Read at: PubMed
  • Published on 6/1/2024

    Kearney CM, Sangani R, Shankar D, O'Connor GT, Law AC, Walkey AJ, Bosch NA. Comparative Effectiveness of Mepolizumab, Benralizumab, and Dupilumab among Patients with Difficult-to-Control Asthma: A Multicenter Retrospective Propensity-matched Analysis. Ann Am Thorac Soc. 2024 Jun; 21(6):866-874. PMID: 38241013.

    Read at: PubMed
  • Published on 1/1/2024

    Shankar DA, Hawkins F, Alysandratos KD, Wilson KC, Walkey AJ, Bosch NA, Law AC. Uptake of Antifibrotics for Patients with Idiopathic Pulmonary Fibrosis: 2016-2022. Ann Am Thorac Soc. 2024 Jan; 21(1):170-173. PMID: 37879035.

    Read at: PubMed
  • Published on 6/1/2023

    Pang B, Kearney L, Maccarone J, Zhang J, Kearney C, Sangani R, Shankar DA, Gillmeyer KR, Law AC, Bosch NA. Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia. Ann Am Thorac Soc. 2023 Jun; 20(6):917-920. PMID: 36867519.

    Read at: PubMed
  • Published on 4/15/2023

    Mesfin N, Sangani R, Shankar DA, Reardon C. New Frontiers in Therapeutics for Interstitial Lung Diseases. Am J Respir Crit Care Med. 2023 Apr 15; 207(8):1089-1091. PMID: 36735934.

    Read at: PubMed
  • Published on 4/3/2023

    Shankar DA, Bosch NA, Walkey AJ, Law AC. Practice Changes Among Patients Without COVID-19 Receiving Mechanical Ventilation During the Early COVID-19 Pandemic. Crit Care Explor. 2023 Apr; 5(4):e0889. PMID: 37025306.

    Read at: PubMed
  • Published on 4/1/2023

    Shankar DA, Walkey AJ, Hawkins FJ, Bosch NA, Peterson D, Law AC. Hospital-level variation in practices and outcomes for patients with severe acute exacerbations of idiopathic pulmonary fibrosis: a retrospective multicentre cohort study. BMJ Open Respir Res. 2023 Apr; 10(1). PMID: 37076251.

    Read at: PubMed
  • Published on 9/1/2022

    Kathuria H, Shankar D, Cobb V, Newman J, Bulekova K, Werntz S, Borrelli B. Integrating Social Determinants of Health With Tobacco Treatment for Individuals With Opioid Use Disorder: Feasibility and Acceptability Study of Delivery Through Text Messaging. JMIR Form Res. 2022 Sep 01; 6(9):e36919. PMID: 36048509.

    Read at: PubMed

View 3 more publications: View full profile at BUMC

View all profiles